Vaccine and Infectious Disease Division

Scientist with petri dish

Featured News from VIDD

Dr. Peter Guarino

Welcome new SCHARP Director Dr. Peter Guarino

Please join VIDD in welcoming new SCHARP Director Dr. Peter Guarino. Peter will manage overall operations and provide leadership and oversight to SCHARP’s four operational units: Data Analytics, Data Management, Project Management, and Technology and Software Systems.  Read more >

More Featured News from VIDD >

Upcoming VIDD Events

Seminar
Michael Gale, PhD
Tuesday, April 21

Seminar
Connie Celum, MD, MPH
Tuesday, April 28

VIDD Faculty Stories

Identifying biomarkers for HIV prevention with Ying Huang
Biomarkers, objects that indicate something more complex and hard to measure, can be used to diagnose and/or predict diseases. In randomized HIV vaccine clinical trials, a certain immune response (the biomarker) is measured post randomization and the question is whether the vaccine’s effect on those immune responses can predict the vaccine’s effect in preventing HIV infection.

More VIDD Faculty Stories >

VIDD Publication Spotlight

Off target effects of rectal tenofovir gel
The antiviral tenofovir is a widely used drug for HIV prevention and treatment as an oral pill. The Microbicides Trial Network (MTN) phase 1 clinical trial was designed to detect possible subtle yet important ‘off target’ effects from rectal 1% tenofovir gel formulation treatment.

More VIDD News >

Find VIDD Faculty

International Spotlight

Uganda
Uganda offers a unique setting to study the impact of infections on the development and clinical course of several cancers.

More International Programs >>

VIDD Announcements

VIDD highlights promotions, new hires, honors/awards and goings of its faculty and staff.